Obesity Surgery

, Volume 23, Issue 1, pp 103–110 | Cite as

Acute Improvement in Insulin Resistance After Laparoscopic Roux-en-Y Gastric Bypass: Is 3 Days Enough to Correct Insulin Metabolism?

  • Gil Faria
  • John Preto
  • Eduardo Lima da Costa
  • João Tiago Guimarães
  • Conceição Calhau
  • António Taveira-Gomes
Clinical Research



Although medium- to long-term improvement in insulin resistance and T2DM after Roux-en-Y gastric bypass (RYGB) is well documented, few studies have analyzed the acute effects after surgery. Understanding these effects might help explain the physiologic adjustments after surgery and help in managing insulin resistance and controlling the hypoglycemic treatment for bariatric patients.


We recruited a prospective cohort of 55 consecutive female patients that underwent primary laparoscopic RYGB between January and June/2011. Blood samples were collected preoperatively and at the first, third, and fifth post-operative days after an overnight fast.


There was a significant increase in homeostasis model assessment for insulin resistance (HOMA-IR) on day 1 (2.36 vs 3.12; p = 0.032), followed by a rapid decrease from day 3 onward (3.12 vs 1.70; <0.001). We found a statistically significant difference (p < 0.05) at all time points compared with baseline. HOMA-IR levels at POD5 were 47 % lower than baseline values and were not significantly different from values at 6 months (1.24 vs 0.93; p = 0.09). The blood levels of glucose and insulin closely matched those of HOMA-IR.


RYGB results in a rapid improvement in insulin resistance and a clinically significant decrease in fasting glucose and insulin levels. This improvement is significant at the 3rd post-operative day, and by the 5th day, patients express insulin resistance levels that are similar to those expressed at 6 months after surgery. This work highlights the acute metabolic impact of surgery. Understanding the behavior of insulin and glucose after surgery might improve our knowledge of the pathophysiology of diabetes and lead to novel therapies and tailored surgical approaches.


Roux-en-Y gastric bypass Insulin resistance Metabolic surgery 


  1. 1.
    Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am. 2011;95(5):875–92.PubMedCrossRefGoogle Scholar
  2. 2.
    Wickremesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg. 2005;15(4):474–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Nannipieri M, Mari A, Anselmino M, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96(9):E1372–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Laferrère B. Do we really know why diabetes remits after gastric bypass surgery? Endocrine. 2011;40(2):162–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Meijer RI, van Wagensveld BA, Siegert CE, et al. Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg. 2011;146(6):744–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Foo J, Krebs J, Hayes MT, et al. Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery. Obes Surg. 2011;21(12):1914–20.PubMedCrossRefGoogle Scholar
  8. 8.
    Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev. 2012;13(4):316–28.PubMedCrossRefGoogle Scholar
  9. 9.
    Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50. discussion 350–2.PubMedCrossRefGoogle Scholar
  10. 10.
    Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84. discussion 84–5.PubMedGoogle Scholar
  11. 11.
    Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–95.PubMedCrossRefGoogle Scholar
  12. 12.
    Friedewald W, Levy R. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499.PubMedGoogle Scholar
  13. 13.
    Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.PubMedCrossRefGoogle Scholar
  14. 14.
    Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. 2009. p. 1640–5.Google Scholar
  15. 15.
    Woelnerhanssen B, Peterli R, Steinert RE, et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial. Surg Obes Relat Dis. 2011;7(5):561–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Braun S, Bitton-Worms K, LeRoith D. The link between the metabolic syndrome and cancer. Int J Biol Sci. 2011;7(7):1003–15.PubMedCrossRefGoogle Scholar
  17. 17.
    Reed MA, Pories WJ, Chapman W, et al. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. J Clin Endocrinol Metab. 2011;96(8):2525–31.PubMedCrossRefGoogle Scholar
  18. 18.
    Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes Relat Metab Disord. 2010;34(3):462–71.CrossRefGoogle Scholar
  19. 19.
    Isbell JM, Tamboli RA, Hansen EN, et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care. 2010;33(7):1438–42.PubMedCrossRefGoogle Scholar
  20. 20.
    Camastra S, Gastaldelli A, Mari A, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia. 2011;54(8):2093–102.PubMedCrossRefGoogle Scholar
  21. 21.
    Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg. 2010;14(1):15–23.PubMedCrossRefGoogle Scholar
  22. 22.
    Lima MMO, Pareja JC, Alegre SM, et al. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(8):3871–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236–42.PubMedCrossRefGoogle Scholar
  24. 24.
    Ashrafian H, Athanasiou T, Li JV, et al. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev. 2011;12(5):e257–72.PubMedCrossRefGoogle Scholar
  25. 25.
    Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab. 2009;35(6 Pt 2):518–23.PubMedCrossRefGoogle Scholar
  26. 26.
    Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252(6):966–71.PubMedCrossRefGoogle Scholar
  27. 27.
    Plum L, Ahmed L, Febres G, et al. Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss. Obesity (Silver Spring). 2011;19(11):2149–57.CrossRefGoogle Scholar
  28. 28.
    Ballantyne GH, Wasielewski A, Saunders JK. The surgical treatment of type II diabetes mellitus: changes in HOMA insulin resistance in the first year following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB). Obes Surg. 2009;19(9):1297–303.PubMedCrossRefGoogle Scholar
  29. 29.
    Lee W-J, Lee Y-C, Ser K-H, et al. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg. 2008;18(9):1119–25.PubMedCrossRefGoogle Scholar
  30. 30.
    Ballantyne GH, Farkas D, Laker S, et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16(9):1189–97.PubMedCrossRefGoogle Scholar
  31. 31.
    Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15(4):462–73.PubMedCrossRefGoogle Scholar
  32. 32.
    Thorell A, Efendic S, Gutniak M, et al. Insulin resistance after abdominal surgery. Br J Surg. 1994;81(1):59–63.PubMedCrossRefGoogle Scholar
  33. 33.
    Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Morínigo R, Lacy AM, Casamitjana R, et al. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg. 2006;16(12):1594–601.PubMedCrossRefGoogle Scholar
  35. 35.
    Liu Y, Zhou Y, Wang Y, et al. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1. Obes Surg. 2011;21(9):1424–31.PubMedCrossRefGoogle Scholar
  36. 36.
    Perugini RA, Malkani S. Remission of type 2 diabetes mellitus following bariatric surgery: review of mechanisms and presentation of the concept of ‘reversibility’. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):119–28.PubMedCrossRefGoogle Scholar
  37. 37.
    Laferrère B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes Relat Metab Disord. 2011;35 Suppl 3:S22–5.CrossRefGoogle Scholar
  38. 38.
    Yin DP, Gao Q, Ma LL, et al. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice. Ann Surg. 2011;254(1):73–82.PubMedCrossRefGoogle Scholar
  39. 39.
    Laferrère B. Effect of gastric bypass surgery on the incretins. Diabetes Metab. 2009;35(6 Pt 2):513–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Scheen AJ, De Flines J, De Roover A, et al. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives. Diabetes Metab. 2009;35(6 Pt 2):537–43.PubMedCrossRefGoogle Scholar
  41. 41.
    Chambers AP, Jessen L, Ryan KK, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology. 2011;141(3):950–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Bikman BT, Zheng D, Pories WJ, et al. Mechanism for improved insulin sensitivity after gastric bypass surgery. J Clin Endocrinol Metab. 2008;93(12):4656–63.PubMedCrossRefGoogle Scholar
  43. 43.
    de Carvalho CP, Marin DM, de Souza AL, et al. GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism. Obes Surg. 2009;19(3):313–20.PubMedCrossRefGoogle Scholar
  44. 44.
    Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353(3):249–54.PubMedCrossRefGoogle Scholar
  45. 45.
    Meirelles K, Ahmed T, Culnan DM, et al. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg. 2009;249(2):277–85.PubMedCrossRefGoogle Scholar
  46. 46.
    Dunn JP, Abumrad NN, Breitman I, et al. Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care. 2012;35(1):137–42.Google Scholar
  47. 47.
    Lin E, Liang Z, Frediani J, et al. Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab. 2010;299(5):E706–12.PubMedCrossRefGoogle Scholar
  48. 48.
    Lin E, Davis SS, Srinivasan J, et al. Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass. Am Surg. 2009;75(6):498–502. discussion 502–3.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Gil Faria
    • 1
    • 2
    • 5
  • John Preto
    • 1
    • 2
  • Eduardo Lima da Costa
    • 1
    • 2
  • João Tiago Guimarães
    • 3
    • 4
  • Conceição Calhau
    • 3
  • António Taveira-Gomes
    • 1
    • 2
  1. 1.Department of Surgery, Faculty of MedicineUniversity of PortoPortoPortugal
  2. 2.Department of SurgerySão João Medical CenterPortoPortugal
  3. 3.Department of Biochemistry, Faculty of MedicineUniversity of PortoPortoPortugal
  4. 4.Department of Clinical PathologySão João Medical CenterPortoPortugal
  5. 5.HSJ—Cirurgia Geral Piso 5PortoPortugal

Personalised recommendations